Research advances in liver injury associated with thyroid dysfunction
- VernacularTitle:甲状腺功能异常相关肝损伤的研究进展
- Author:
Ye LIU
1
;
Jingyan WU
1
;
Qinyang ZHONG
1
;
Wu LI
1
Author Information
- Publication Type:Review
- Keywords: Hyperthyroidism; Hypothyroidism; Liver Injury; Therapeutics
- From: Journal of Clinical Hepatology 2026;42(1):217-221
- CountryChina
- Language:Chinese
- Abstract: The thyroid gland is the largest endocrine organ in the human body， and its dysfunction can cause varying degrees of liver injury， leading to liver failure in severe cases. Patients with hyperthyroidism have a relatively high incidence rate of liver dysfunction， manifesting as hepatocellular injury or cholestatic liver injury， while hypothyroidism is closely associated with metabolic dysfunction-associated fatty liver disease. Autoimmune thyroid diseases， including Hashimoto’s thyroiditis and subacute thyroiditis， are commonly comorbid with autoimmune liver disease. In addition， medications such as antithyroid drugs， amiodarone， and immune checkpoint inhibitors can cause severe liver injury through direct toxicity or immune-mediated mechanisms. Although significant progress has been achieved in related diagnosis and treatment techniques in recent years， there are still many challenges in pathogenesis， individualized treatment strategies， early warning， and prognostic evaluation. This article systematically reviews the research advances in liver injury associated with thyroid dysfunction and proposes the directions for future research， in order to provide guidance for clinical diagnosis and treatment.
